Before taking Keppra XR, tell your healthcare provider about any medical conditions, allergies, or medications you are taking.
Keppra XR is a prescription anticonvulsant medication used to treat partial-onset seizures, also called focal seizures, in people aged 12 years and older with epilepsy.
It contains levetiracetam, an active ingredient that helps reduce abnormal electrical activity in the brain. The medication works partly by binding to a protein called synaptic vesicle protein 2A (SV2A), which is involved in communication between nerve cells.
Although Keppra XR can help control seizures, it may cause side effects involving mood, behaviour, alertness, coordination, and other body functions.
Some people may also develop serious allergic reactions or skin conditions that require immediate medical attention.
Your healthcare provider will review your medical history, kidney function, seizure frequency, and other medications before recommending treatment.
Allergic Reactions and Hypersensitivity
Do not take Keppra XR if you have a known allergy to levetiracetam or any other ingredient in the medication.
An allergic reaction occurs when the immune system reacts abnormally to a medication or another substance.
Allergic reactions to levetiracetam may range from mild skin symptoms to severe, potentially life-threatening reactions.
Possible symptoms include:
- Skin Rash: Red, irritated, or itchy patches that develop on the skin.
- Hives: Raised, itchy bumps that may appear suddenly.
- Facial Swelling: Swelling around the eyes, lips, or face.
- Tongue or Throat Swelling: Swelling that may interfere with swallowing or breathing.
- Difficulty Breathing: Shortness of breath, wheezing, or throat tightness.
- Dizziness or Fainting: Symptoms that may occur during a severe allergic reaction.
Keppra XR has been associated with serious allergic reactions, including anaphylaxis and angioedema.
Angioedema is swelling that develops beneath the skin, often around the lips, tongue, face, or throat.
Anaphylaxis is a severe allergic reaction that may affect breathing, blood pressure, and circulation.
Stop taking Keppra XR and seek emergency medical attention if you develop difficulty breathing, swelling of the tongue or throat, or symptoms of anaphylaxis.
Tell your healthcare provider if you have previously experienced an allergic reaction to levetiracetam or a related medication, including brivaracetam.
Mood Changes and Behavioral Problems
Keppra XR may cause changes in mood or behavior in some people.
Although levetiracetam helps regulate certain processes involved in nerve cell communication, it may also affect how some individuals feel, think, or respond to situations.
Behavioural changes have been reported in people taking levetiracetam, including irritability, aggression, agitation, and unusual emotional reactions.
Possible symptoms include:
- Irritability: Becoming frustrated or upset more easily than usual.
- Anger: Experiencing unusual or frequent episodes of anger.
- Aggressive Behavior: Acting in ways that are unusually hostile or confrontational.
- Anxiety: Feeling excessively worried, nervous, or restless.
- Depression: Experiencing persistent sadness, low mood, or loss of interest in activities.
- Agitation: Feeling unusually restless or unable to remain calm.
- Mood Swings: Sudden changes in emotional state.
- Sleep Problems: Difficulty sleeping or changes in normal sleep patterns.
These effects may develop after starting Keppra XR or following an increase in dosage.
Some changes may be mild, while others can interfere with relationships, work, school, or everyday activities.
Family members or caregivers may notice behavioral changes before the person taking the medication recognizes them.
Tell your healthcare provider if you have a history of depression, anxiety, behavioral problems, or other psychiatric conditions.
Contact your healthcare provider promptly if you or someone close to you notices significant changes in mood or behavior.
Your healthcare provider may recommend additional monitoring, dosage adjustments, or another anticonvulsant medication if necessary.
Do not stop taking Keppra XR suddenly because of mood changes without receiving medical guidance, unless emergency care is needed for a serious reaction.
Suicidal Thoughts and Behavior
Anticonvulsant medications, including Keppra XR, may increase the risk of suicidal thoughts or behavior in a small number of patients.
This warning applies to antiepileptic medications used for epilepsy and certain other conditions.
Clinical studies involving several anticonvulsant medications identified a slightly increased risk of suicidal thoughts or behavior compared with placebo.
Although the overall risk was low, these symptoms require serious attention.
Possible warning signs include:
- New or Worsening Depression: Persistent sadness, hopelessness, or loss of interest in normal activities.
- Thoughts of Self-Harm: Thinking about hurting yourself.
- Suicidal Thoughts: Thinking about ending your life.
- Unusual Behavior Changes: Acting differently from normal in ways that cause concern.
- Severe Agitation: Intense restlessness or emotional distress.
- Increased Anxiety: Sudden or worsening feelings of fear or nervousness.
- Social Withdrawal: Avoiding family, friends, or normal activities.
- Significant Mood Changes: Sudden emotional changes that are difficult to explain.
These symptoms can develop at different times during treatment.
Tell your healthcare provider if you have a history of depression, self-harm, or suicidal thoughts before starting Keppra XR.
You and those close to you should remain alert for new or worsening mood or behavioral changes.
Contact your healthcare provider immediately if you develop thoughts of self-harm or suicide.
If you feel unable to keep yourself safe or believe you may act on suicidal thoughts, seek emergency medical attention or call your local emergency number.
Your healthcare provider will determine whether your treatment needs to be changed while maintaining appropriate seizure protection.
Kidney Disease and Renal Impairment
Keppra XR should be used with caution in people with kidney disease or reduced kidney function.
The kidneys play an important role in removing levetiracetam from the body.
Most levetiracetam is eliminated through the kidneys, largely without being changed into another substance.
When kidney function decreases, the medication may remain in the bloodstream longer.
This can increase medication exposure and the likelihood of certain side effects.
People with reduced kidney function may require lower doses of Keppra XR.
Your healthcare provider may assess kidney function using blood tests, including serum creatinine and an estimated glomerular filtration rate (eGFR).
Possible symptoms of reduced kidney function include:
- Changes in Urination: Producing less urine or noticing changes in urination.
- Swelling: Fluid buildup in the feet, ankles, or hands.
- Fatigue: Persistent tiredness or weakness.
- Nausea: Ongoing stomach discomfort.
- Reduced Appetite: A decreased desire to eat.
However, kidney disease may develop without noticeable symptoms.
Tell your healthcare provider if you have kidney disease, reduced kidney function, or receive dialysis.
Your healthcare provider will determine the appropriate dosage based on your kidney function and seizure control.
Do not reduce or increase your Keppra XR dosage without medical advice.
Drowsiness, Fatigue, and Reduced Alertness
Keppra XR may cause sleepiness, dizziness, and fatigue, particularly when treatment begins or the dosage increases.
These effects can interfere with concentration, reaction time, and the ability to perform certain activities safely.
Common symptoms include:
- Drowsiness: Feeling unusually sleepy during the day.
- Fatigue: Persistent tiredness or reduced energy.
- Dizziness: Feeling lightheaded or unsteady.
- Difficulty Concentrating: Problems focusing on tasks.
- Slower Reactions: Taking longer than usual to respond to situations.
- Reduced Alertness: Difficulty remaining fully attentive.
Some people experience these effects during the first few weeks of treatment.
For others, symptoms may improve as the body adjusts to the medication.
However, persistent or severe drowsiness should be evaluated by your healthcare provider.
Avoid driving, operating heavy machinery, or performing potentially dangerous activities until you understand how Keppra XR affects you.
Alcohol and other sedating medications may worsen dizziness, sleepiness, or reduced coordination.
Contact your healthcare provider if these side effects interfere with your daily activities.
Coordination Problems and Difficulty Walking
Levetiracetam may occasionally cause problems with balance, walking, or muscle coordination.
These symptoms may make it more difficult to perform activities that require controlled movements.
Possible effects include:
- Unsteady Walking: Difficulty maintaining normal balance.
- Poor Coordination: Trouble controlling movements accurately.
- Dizziness: Feeling unsteady or off-balance.
- Clumsiness: Dropping objects or having difficulty with precise movements.
- Increased Risk of Falls: Losing balance more easily than usual.
Coordination difficulties may be more noticeable when treatment begins or after a dosage increase.
The risk may also be greater if you take other medications that cause dizziness or affect coordination.
Tell your healthcare provider if you develop new balance problems, unusual clumsiness, or difficulty walking.
Seek urgent medical attention if these symptoms appear suddenly or occur with severe weakness, speech problems, or loss of consciousness.
Medication Interactions
Keppra XR may interact with certain medications, supplements, and substances that affect the central nervous system.
Unlike some anticonvulsant medications, levetiracetam has relatively few clinically significant interactions involving liver enzymes.
This is partly because levetiracetam is not extensively metabolized by the liver.
However, combining Keppra XR with medications that cause drowsiness or dizziness may increase certain side effects.
Important considerations include:
- Other Anticonvulsant Medications: Your healthcare provider may prescribe Keppra XR alongside other epilepsy medications. Some combinations may increase dizziness, fatigue, or coordination problems.
- Sedating Antihistamines: Medications such as diphenhydramine may increase drowsiness.
- Sleeping Medications: Certain sleep aids and sedatives may increase reduced alertness.
- Opioid Pain Medications: Combining opioids with Keppra XR may increase sleepiness and dizziness.
- Alcohol: Drinking alcohol may worsen sedation, balance problems, and impaired coordination.
- Herbal Supplements: Certain supplements may cause sedation or affect seizure control.
Tell your healthcare provider about all prescription medications, over-the-counter drugs, vitamins, and herbal products you take.
Your healthcare provider or pharmacist can review possible interactions and determine whether adjustments are necessary.
Do not start, stop, or change another anticonvulsant medication without medical advice.
Pregnancy and Seizure Control
Tell your healthcare provider if you are pregnant, planning to become pregnant, or think you may be pregnant before taking Keppra XR.
Managing epilepsy during pregnancy requires careful medical supervision.
Uncontrolled seizures can pose serious risks to both the pregnant person and the developing baby.
Levetiracetam has been studied during pregnancy, and available human pregnancy registry data are generally reassuring regarding the risk of major birth defects when it is used alone.
However, no medication can be considered completely risk-free during pregnancy.
Your healthcare provider will consider your seizure type, seizure frequency, medical history, and other medications when reviewing your treatment.
Changes in Levetiracetam Levels During Pregnancy
Pregnancy can affect how quickly the body eliminates levetiracetam.
As pregnancy progresses, levetiracetam concentrations in the bloodstream may decrease, particularly during the third trimester.
Lower medication levels may reduce seizure control in some patients.
Your healthcare provider may recommend monitoring seizure frequency and, when appropriate, measuring levetiracetam blood concentrations.
Some patients may require dosage adjustments during pregnancy.
After delivery, medication levels may increase again as kidney function and other body processes return toward their usual state.
Your healthcare provider may therefore reassess your dosage after childbirth.
Do not stop taking Keppra XR if you become pregnant without consulting your healthcare provider. Abrupt discontinuation may cause seizures to return or become more frequent.
Breastfeeding
Levetiracetam passes into human breast milk.
However, breastfeeding may still be possible during treatment, depending on your medical condition, prescribed dosage, and your baby’s health.
Available information suggests that many infants exposed to levetiracetam through breast milk do not experience significant complications.
Nevertheless, some infants may develop sleepiness, feeding difficulties, or other symptoms that require evaluation.
If you breastfeed while taking Keppra XR, your healthcare provider may recommend watching your baby for:
- Unusual Sleepiness: Sleeping excessively or having difficulty waking for feeds.
- Poor Feeding: Drinking less milk than usual.
- Reduced Alertness: Appearing unusually tired or less responsive.
- Poor Weight Gain: Not gaining weight as expected.
Tell your healthcare provider if you notice any concerning symptoms.
Your healthcare provider will weigh the benefits of breastfeeding against the potential risks of medication exposure.
Do not discontinue your epilepsy medication without medical advice.
Blurred Vision and Other Eye Problems
Some people taking levetiracetam have reported blurred vision, double vision, or other visual disturbances.
Blurred vision means objects appear less clear than normal.
Double vision, also called diplopia, occurs when a person sees two images of the same object.
Although vision changes are not among the most prominent side effects of Keppra XR, they may interfere with activities that require clear eyesight.
Possible symptoms include:
- Blurred Vision: Difficulty seeing objects clearly.
- Double Vision: Seeing two images instead of one.
- Difficulty Focusing: Problems maintaining clear vision during normal activities.
- Visual Discomfort: Unusual discomfort or strain affecting the eyes.
Vision changes may also occur because of seizures, other medications, or an unrelated eye condition.
Tell your healthcare provider if you develop new or persistent vision problems while taking Keppra XR.
Avoid driving or operating machinery if your eyesight is affected.
Seek urgent medical attention if you experience sudden vision loss, severe eye pain, or vision changes accompanied by severe headache, weakness, or confusion.
These symptoms may indicate a medical condition requiring immediate evaluation rather than a typical medication side effect.
Liver Problems and Liver Function
Keppra XR is not extensively metabolized by the liver, and most of the medication is eliminated through the kidneys.
For this reason, significant liver-related problems are uncommon compared with some other anticonvulsant medications.
However, rare cases of liver injury and abnormal liver function tests have been reported in people taking levetiracetam.
Possible symptoms include:
- Jaundice: Yellowing of the skin or whites of the eyes.
- Dark Urine: Urine becoming unusually dark.
- Upper Abdominal Pain: Discomfort in the upper-right part of the abdomen.
- Persistent Nausea: Ongoing stomach upset.
- Loss of Appetite: Reduced interest in eating.
- Unusual Fatigue: Persistent tiredness or weakness.
- Pale Stools: Bowel movements becoming lighter than normal.
Tell your healthcare provider if you have liver disease or a history of abnormal liver function tests.
Routine liver function monitoring is not required for everyone taking Keppra XR solely because of the medication. However, your healthcare provider may recommend testing when clinically necessary.
Contact your healthcare provider promptly if you develop symptoms suggesting liver injury.
Severe liver-related symptoms may occasionally be part of a serious medication hypersensitivity reaction.
Serious Skin Reactions and DRESS Syndrome
Rarely, levetiracetam may cause serious skin reactions, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS).
These conditions are uncommon but can be life-threatening.
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
SJS and TEN are severe reactions that damage the skin and mucous membranes.
Warning signs may include:
- A widespread or painful skin rash.
- Skin blisters or peeling.
- Fever.
- Painful sores inside the mouth.
- Red or irritated eyes.
- Severe skin tenderness.
These symptoms require immediate medical evaluation.
DRESS Syndrome
DRESS is a serious medication reaction that can affect the skin and internal organs.
It may develop approximately two to eight weeks after starting levetiracetam, although timing can vary.
Possible symptoms include:
- Fever: An unexplained increase in body temperature.
- Skin Rash: A widespread rash that may or may not be present.
- Swollen Lymph Nodes: Enlarged or tender glands.
- Facial Swelling: Unusual swelling around the face.
- Liver Problems: Symptoms such as jaundice or dark urine.
- Kidney Problems: Changes in urination or kidney function.
- Breathing Problems: Symptoms caused by inflammation affecting the lungs.
DRESS may cause inflammation and injury involving the liver, kidneys, lungs, heart, or other organs.
Stop taking Keppra XR and seek immediate medical attention if you develop symptoms suggesting a serious skin reaction or DRESS.
Do not restart the medication after a suspected serious hypersensitivity reaction unless a specialist determines that doing so is safe.
Stopping Keppra XR and Withdrawal Seizures
Do not stop taking Keppra XR suddenly without consulting your healthcare provider.
Keppra XR helps control seizures by affecting processes involved in communication between nerve cells.
When anticonvulsant treatment is interrupted or stopped abruptly, seizure protection may decrease.
This can cause seizures to return or become more frequent.
In some cases, sudden withdrawal may increase the risk of prolonged or repeated seizures.
A particularly serious complication is status epilepticus, which occurs when a seizure lasts too long or repeated seizures happen without recovery between them.
Status epilepticus is a medical emergency.
If Keppra XR needs to be discontinued, your healthcare provider will usually recommend gradually reducing the dosage.
The appropriate withdrawal schedule depends on your seizure history, current dosage, kidney function, and other epilepsy medications.
However, severe allergic reactions or other serious complications may require immediate discontinuation under urgent medical supervision.
Do not reduce your dosage, intentionally skip doses, or stop Keppra XR simply because you have not experienced a seizure recently.
Continue taking the medication as prescribed unless your healthcare provider instructs you otherwise.
When to Contact Your Healthcare Provider
Contact your healthcare provider if you experience persistent drowsiness, dizziness, worsening seizures, new balance problems, or significant changes in mood or behavior while taking Keppra XR.
Tell your healthcare provider if you have kidney disease, become pregnant, are breastfeeding, or begin taking additional medications.
Seek prompt medical attention if you develop a new rash, unexplained fever, swollen lymph nodes, or symptoms suggesting liver problems.
Seek emergency medical attention if you experience difficulty breathing, swelling of the tongue or throat, a severe blistering skin reaction, a seizure lasting five minutes or longer, or repeated seizures without recovery.
Keppra XR can help control focal seizures, but safe treatment requires regular dosing, careful monitoring, and attention to possible side effects. Following your prescribed treatment plan, reporting changes in mood or behavior, and avoiding abrupt discontinuation can help reduce treatment-related complications.
REVIEWS